PDI Launches Advanced Skin Antisepsis Platform

PDI, leader in infection prevention education, support and products has launched its new Advanced Skin Antisepsis platform, PDI Prevantics. Under this platform, the company is investing in innovations that provide the most efficient and advanced evidence-based solutions for preventing healthcare associated infections.

Read More »

PDI Launches Educational Packaging for Instant Hand Sanitizing Wipes

PDI, owner of Sani-Hands® Instant Hand Sanitizing wipes, has announced the launch of new educational packaging to help aid in hand hygiene for patients and education at the bedside. Four educational “when to use” icons have been added to the Sani-Hands Bedside Pack to help healthcare staff communicate critical opportunities for patients to practice hand hygiene1—after using the bathroom, before eating and drinking, after contact with others and after coughing and sneezing.

Read More »

Update on Meningitis Outbreak Caused by Mass. Compounding Pharmacy

The Nov/Dec issue of PSQH included news coverage and commentary about the fungal meningitis outbreak caused in late 2012 by contaminated medications that had been shipped throughout the country by a compounding pharmacy in Massachusetts. In The New England Journal of Medicine, Smith et al. report that as of Dec. 10, 2012, the outbreak resulted in 590 reported cases of infection in 19 states and 37 patient deaths. According to the Institute for Safe Medication Practices, this outbreak is one of the most harmful adverse events ever associated with compounding pharmacies in the United States.

Read More »